The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact ST&R.
Drug products – institution of patent infringement investigation 337-TA-1447 of drug products containing C-type natriuretic peptide variants and components thereof (complainant BioMarin Pharmaceutical Inc.; respondents located in Denmark, Germany, and the U.S.)
Wearable devices – decision to rescind remedial orders issued in investigation 337-TA-1266 of wearable electronic devices with ECG functionality and components thereof
Copyright © 2025 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.